Community perspective on child-friendly medications for drug-resistant TB: importance, priorities and advocacy.
Viljoen L, Acaba J, Agbassi YJP, Beko B, Goslett C, Hoddinott G, Kumar B, Kumar RG, McKenna L, Moses G, Sachs T, Seidel S, von Delft A.
Viljoen L, et al. Among authors: kumar rg, kumar b.
Int J Tuberc Lung Dis. 2023 Sep 1;27(9):655-657. doi: 10.5588/ijtld.23.0164.
Int J Tuberc Lung Dis. 2023.
PMID: 37608482
Free PMC article.
No abstract available.